Chargement en cours...
IGF-1 and Anti-VEGF in ROP: Has the time come?
Treatment of ROP is currently evolving. Novel therapeutic options are emerging that have the potential to complement existing therapies and improve treatment outcomes. However, any new therapeutic options must be thoroughly evaluated before existing (and successful) treatment paradigms can be amende...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4197141/ https://ncbi.nlm.nih.gov/pubmed/25300950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000365132 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|